학술논문
The Prosid Study: Evaluating Efficacy and Safety of Intravenous Immunoglobulin (IVIG) 10% in Primary Infection Prophylaxis in Patients with Chronic Lymphocytic Leukemia- Study Design
Document Type
Abstract
Source
In Blood 5 November 2020 136 Supplement 1:20-21
Subject
Language
ISSN
0006-4971